Tissue Array Specification Sheet
| Product Name: | Multiple organ diseased tissue array, 30 cases/60 cores, replaced by MC801 3 Slides Price: $277 , 5 Slides Price: $452 |
| Array Panel: | Multiple organ diseased tissue microarray, including 30 cases of 11 types of organs carcinoma (brain, breast, colon, esophagus, kidney, liver, lung, stomach, striated muscles, tongue and uterus), duplicate cores per case |
| Cat No. |
Cases |
Layout |
Cores |
Diameter |
Thickness |
Standard IHC |
| BC00012 |
30 |
6 x 10 |
60 |
1.5 mm |
5 µm |
Anti-Cytokeratin (CK) confirmed |
Microarray Panel Display
| Legend: | Bra - Brain,
Bre - Breast,
Col - Colon,
Eso - Esophagus,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Sto - Stomach,
Str - Striated muscles,
Ton - Tongue,
Ute - Uterus
- Malignant tumor,
- Benign tumor,
- Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
| A1 |
1 |
F |
55 |
Liver |
Hepatocellular carcinoma |
III |
Malignant |
| A2 |
2 |
F |
55 |
Stomach |
Mucous cell carcinoma |
III |
Malignant |
| A3 |
3 |
M |
65 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
| A4 |
4 |
M |
72 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| A5 |
5 |
F |
29 |
Brain |
Syncytial meningioma |
- |
Benign |
| A6 |
6 |
F |
55 |
Uterus |
Adenocarcinoma |
III |
Malignant |
| A7 |
7 |
F |
24 |
Uterus |
Alveolar Rhabdomyosarcoma |
- |
Malignant |
| A8 |
8 |
M |
37 |
Colon |
Adenocarcinoma |
II |
Malignant |
| A9 |
9 |
F |
48 |
Breast |
Infiltrating duct carcinoma |
- |
Malignant |
| A10 |
10 |
M |
70 |
Lung |
Adenocarcinoma |
III |
Malignant |
| B1 |
11 |
F |
55 |
Liver |
Hepatocellular carcinoma |
III |
Malignant |
| B2 |
12 |
F |
55 |
Stomach |
Mucous cell carcinoma |
III |
Malignant |
| B3 |
13 |
M |
65 |
Esophagus |
Squamous cell carcinoma |
- |
Malignant |
| B4 |
14 |
M |
72 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| B5 |
15 |
F |
29 |
Brain |
Syncytial meningioma |
- |
Benign |
| B6 |
16 |
F |
55 |
Uterus |
Inflammatory necrosis tissue |
- |
Malignant |
| B7 |
17 |
F |
24 |
Uterus |
Alveolar Rhabdomyosarcoma |
- |
Malignant |
| B8 |
18 |
M |
37 |
Colon |
Adenocarcinoma |
II |
Malignant |
| B9 |
19 |
F |
48 |
Breast |
Infiltrating duct carcinoma |
- |
Malignant |
| B10 |
20 |
M |
70 |
Lung |
Adenosquamous carcinoma |
- |
Malignant |
| C1 |
21 |
F |
32 |
Liver |
Hepatocellular carcinoma |
I |
Malignant |
| C2 |
22 |
M |
57 |
Stomach |
Adenocarcinoma |
III |
Malignant |
| C3 |
23 |
M |
75 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
| C4 |
24 |
M |
72 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| C5 |
25 |
M |
27 |
Brain |
Fibrous meningioma |
- |
Benign |
| C6 |
26 |
F |
50 |
Uterus |
Adenocarcinoma |
I |
Malignant |
| C7 |
27 |
M |
7 |
Striated muscles |
Alveolar rhabdomyosarcoma |
- |
Malignant |
| C8 |
28 |
M |
62 |
Colon |
Adenocarcinoma |
II |
Malignant |
| C9 |
29 |
F |
42 |
Breast |
Fibrofatty tissue |
- |
Malignant |
| C10 |
30 |
M |
60 |
Lung |
Adenocarcinoma |
III |
Malignant |
| D1 |
31 |
F |
32 |
Liver |
Hepatocellular carcinoma |
I |
Malignant |
| D2 |
32 |
M |
57 |
Stomach |
Adenocarcinoma |
III |
Malignant |
| D3 |
33 |
M |
75 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
| D4 |
34 |
M |
72 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| D5 |
35 |
M |
27 |
Brain |
Fibrous meningioma |
- |
Benign |
| D6 |
36 |
F |
50 |
Uterus |
Adenocarcinoma |
I |
Malignant |
| D7 |
37 |
M |
7 |
Striated muscles |
Alveolar rhabdomyosarcoma |
- |
Malignant |
| D8 |
38 |
M |
62 |
Colon |
Adenocarcinoma |
II |
Malignant |
| D9 |
39 |
F |
42 |
Breast |
Fibrofatty tissue |
- |
Malignant |
| D10 |
40 |
M |
60 |
Lung |
Adenocarcinoma |
III |
Malignant |
| E1 |
41 |
M |
63 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
| E2 |
42 |
M |
74 |
Stomach |
Adenocarcinoma |
III |
Malignant |
| E3 |
43 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
II |
Malignant |
| E4 |
44 |
M |
54 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| E5 |
45 |
F |
47 |
Brain |
Syncytial meningioma |
- |
Benign |
| E6 |
46 |
F |
42 |
Uterus |
Smooth muscle and phlegmasia |
- |
Normal |
| E7 |
47 |
M |
38 |
Tongue |
Adenoid cystic carcinoma |
- |
Malignant |
| E8 |
48 |
M |
58 |
Colon |
Adenocarcinoma |
I |
Malignant |
| E9 |
49 |
F |
65 |
Breast |
Infiltrating duct carcinoma |
- |
Malignant |
| E10 |
50 |
M |
57 |
Lung |
Adenocarcinoma |
III |
Malignant |
| F1 |
51 |
M |
63 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
| F2 |
52 |
M |
74 |
Stomach |
Adenocarcinoma |
III |
Malignant |
| F3 |
53 |
M |
62 |
Esophagus |
Smooth muscle and phlegmasia |
- |
Malignant |
| F4 |
54 |
M |
54 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| F5 |
55 |
F |
47 |
Brain |
Syncytial meningioma |
- |
Benign |
| F6 |
56 |
F |
42 |
Uterus |
Smooth muscle and phlegmasia |
- |
Normal |
| F7 |
57 |
M |
38 |
Tongue |
Adenoid cystic carcinoma |
- |
Malignant |
| F8 |
58 |
M |
58 |
Colon |
Adenocarcinoma |
I |
Malignant |
| F9 |
59 |
F |
65 |
Breast |
Infiltrating duct carcinoma |
- |
Malignant |
| F10 |
60 |
M |
57 |
Lung |
Adenocarcinoma |
III |
Malignant |
, . † For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
Staining Scoring: '-' - no staining; '+-' - borderline staining; '+' - weak staining; '++' - moderate staining; '+++' - strong staining; '%' - percentage of positive cells.
TNM grading:
T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum
N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes
M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis